<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="367462">
  <stage>Registered</stage>
  <submitdate>19/11/2014</submitdate>
  <approvaldate>3/12/2014</approvaldate>
  <actrnumber>ACTRN12614001266651</actrnumber>
  <trial_identification>
    <studytitle>Investigation of a new implantable cardiac event recorder (BioMonitor 2) in patients with suspected cardiac arrhythmias</studytitle>
    <scientifictitle>Implantation and signal assessment of BioMonitor 2 in patients with suspected arrhythmias or symptoms suggestive of arrhythmic causes</scientifictitle>
    <utrn />
    <trialacronym>BioMonitor 2 Pilot Study</trialacronym>
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cardiac arrhythmias</healthcondition>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Implantation of an implantable cardiac event recorder in the patients chest just under the skin. The implantation procedure takes less than one minute. The device remains implanted until sufficient information has been gathered for the doctor to diagnose the cardiac arrhythmia or until the battery runs out after about four years. The device automatically records a number of  subcutaneous ECG episodes based on a number of cardiac rhythm related triggers (AF, VT, bradycardia etc).  The patient can also prompt a recording by the device using a patient activator device which is supplied.</interventions>
    <comparator>Nil</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>R-wave amplitude of BioMonitor 2 &gt;= 0.3 mV as measured with an external programming device during the scheduled follow-up visit</outcome>
      <timepoint>1 week follow-up visit</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Assessment of implantation tool set handling by qualitative evaluation by the implanter</outcome>
      <timepoint>Implantation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patient at high risk of developing a clinically important cardiac arrhythmia or undergoing investigation for symptoms suggestive of cardiac arrhythmias or detection of paroxysmal atrial fibrillation following cryptogenic stroke or patients undergoing or having undergone AF ablation</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients implanted with ICD or pacemaker
Patient who is pregnant or breast-feeding
Life expectancy of less than 6 months</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>n/a</concealment>
    <sequence>n/a</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods>For continuous variables descriptive statistics mean, standard deviation and quartiles will be calculated. For nominal or ordinal variables frequencies and proportions will be calculated.</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/12/2014</anticipatedstartdate>
    <actualstartdate>18/12/2014</actualstartdate>
    <anticipatedenddate>22/04/2015</anticipatedenddate>
    <actualenddate>6/07/2015</actualenddate>
    <samplesize>30</samplesize>
    <actualsamplesize>30</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,WA,VIC</recruitmentstate>
    <hospital>Prince of Wales Hospital - Randwick</hospital>
    <hospital>Sydney Adventist Hospital - Wahroonga</hospital>
    <hospital>Hollywood Private Hospital - Nedlands</hospital>
    <hospital>Joondalup Health Campus - Joondalup</hospital>
    <hospital>The Northern Hospital - Epping</hospital>
    <postcode>2031 - Randwick</postcode>
    <postcode>2076 - Wahroonga</postcode>
    <postcode>6009 - Nedlands</postcode>
    <postcode>6027 - Joondalup</postcode>
    <postcode>3076 - Epping</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>BIOTRONIK Australia Pty. Ltd.</primarysponsorname>
    <primarysponsoraddress>Level 4, Building 2
20 Bridge St
Pymble NSW 2073</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>BIOTRONIK Australia Pty. Ltd.</fundingname>
      <fundingaddress>Level 4, Building 2
20 Bridge St
Pymble NSW 2073</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>BioMonitor 2 Pilot Study aims to collect first implantation experience with a new generation of implantable cardiac event recorder.</summary>
    <trialwebsite>none</trialwebsite>
    <publication>n/a</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>South Eastern Sydney Local Health District Ethics Committee</ethicname>
      <ethicaddress>Research Support Office
G71, East Wing 
Edmund Blacket Building
Prince of Wales Hospital
Barker St
Randwick NSW 2031 </ethicaddress>
      <ethicapprovaldate>19/12/2014</ethicapprovaldate>
      <hrec>HREC ref. no. 14/281 (HREC/14/POWH/626)</hrec>
      <ethicsubmitdate>4/11/2014</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Sze-Yuan Ooi</name>
      <address>Prince of Wales Hospital
Eastern Heart Clinic
Barker St
Randwick NSW 2031</address>
      <phone>+61 2 9382 0770</phone>
      <fax />
      <email>SzeYuan.Ooi@ehc.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Falko Thiele</name>
      <address>BIOTRONIK Australia Pty. Ltd.
Level 4, Building 2
20 Bridge St
Pymble NSW 2073</address>
      <phone>+61 2 9497 3719</phone>
      <fax />
      <email>Falko.Thiele@biotronik.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Falko Thiele</name>
      <address>BIOTRONIK Australia Pty. Ltd.
Level 4, Building 2
20 Bridge St
Pymble NSW 2073</address>
      <phone>+61 2 9497 3719</phone>
      <fax />
      <email>Falko.Thiele@biotronik.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Falko Thiele</name>
      <address>Level 4, Building 2
20 Bridge St
Pymble NSW 2073</address>
      <phone>+61 2 9497 3719</phone>
      <fax />
      <email>Falko.Thiele@biotronik.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>